Fradet Y - Search Results

1

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.

Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Stenzl A, et al. Among authors: fradet y. J Urol. 2010 Nov;184(5):1907-13. doi: 10.1016/j.juro.2010.06.148. Epub 2010 Sep 17. J Urol. 2010. PMID: 20850152 Free PMC article. Clinical Trial.

2

Markers of prognosis in superficial bladder cancer.

Fradet Y. Fradet Y. Semin Urol. 1992 Feb;10(1):28-38. Semin Urol. 1992. PMID: 1565901 Review. No abstract available.

3

Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.

Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Draeger BJ. Huland E, et al. Among authors: fradet y. J Urol. 1991 Dec;146(6):1631-6. doi: 10.1016/s0022-5347(17)38202-2. J Urol. 1991. PMID: 1719252

4

Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer.

Tetu B, Fradet Y, Allard P, Veilleux C, Roberge N, Bernard P. Tetu B, et al. Among authors: fradet y. J Urol. 1996 May;155(5):1784-8. J Urol. 1996. PMID: 8627884

5

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group.

Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S. Goldenberg SL, et al. Among authors: fradet y. J Urol. 1996 Sep;156(3):873-7. J Urol. 1996. PMID: 8709351 Clinical Trial.

6

Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder.

Lee E, Schwaibold H, Fradet Y, Huland E, Huland H. Lee E, et al. Among authors: fradet y. J Urol. 1997 Mar;157(3):1070-3. J Urol. 1997. PMID: 9072545

7

Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.

Grégoire M, Fradet Y, Meyer F, Têtu B, Bois R, Bédard G, Charrois R, Naud A. Grégoire M, et al. Among authors: fradet y. J Urol. 1997 May;157(5):1660-4. J Urol. 1997. PMID: 9112500

8

Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.

Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D. Lianes P, et al. Among authors: fradet y. Clin Cancer Res. 1998 May;4(5):1267-71. Clin Cancer Res. 1998. PMID: 9607586

9

Phenotypic characterization of bladder cancer.

Fradet Y. Fradet Y. Eur Urol. 1998;33 Suppl 4:5-6. doi: 10.1159/000052250. Eur Urol. 1998. PMID: 9615196 Review. No abstract available.

10

The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index.

Allard P, Bernard P, Fradet Y, Têtu B. Allard P, et al. Among authors: fradet y. Br J Urol. 1998 May;81(5):692-8. doi: 10.1046/j.1464-410x.1998.00628.x. Br J Urol. 1998. PMID: 9634043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters